Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals-Reference-Cited by-同舟云学术

Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals

Published:2022-03-04 Issue:3 Volume:5 Page:e221048
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Nadkarni Girish N.¹²,Fei Kezhen³⁴,Ramos Michelle A.³⁴,Hauser Diane⁵,Bagiella Emilia³,Ellis Stephen B.²,Sanderson Saskia²,Scott Stuart A.²⁶⁷,Sabin Tatiana³⁴,Madden Ebony⁸,Cooper Richard⁹,Pollak Martin¹⁰,Calman Neil⁴⁵,Bottinger Erwin P.¹²¹¹,Horowitz Carol R.²³⁴

Affiliation:

1. Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York

2. The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York

3. Department of Population Health Sciences and Policy, Icahn School of Medicine at Mount Sinai, New York, New York

4. Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai, New York, New York

5. Institute for Family Health, New York, New York

6. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York

7. Sema4, A Mount Sinai Venture, Stamford, Connecticut

8. National Human Genome Research Institute, Bethesda, Maryland

9. Department of Public Health Sciences, Loyola University Medical School, Maywood, Illinois

10. Division of Nephrology, Harvard Medical School, Boston, Massachusetts

11. Digital Health Center, Hasso Plattner Institute, Potsdam, Germany

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789618/nadkarni_2022_oi_220058_1645727145.34894.pdf

Reference41 articles.

1. Risk of ESRD in the United States.;Albertus;Am J Kidney Dis,2016

2. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.;McClellan;Am J Kidney Dis,1988

3. Surveillance of CKD epidemiology in the US—a joint analysis of NHANES and KEEP.;Myers;Sci Rep,2018

4. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.;Genovese;Science,2010

5. APOL1 risk variants, race, and progression of chronic kidney disease.;Parsa;N Engl J Med,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased risk of kidney failure in patients with genetic kidney disorders;Journal of Clinical Investigation;2024-09-03

2. Defining Risk in APOL1-Associated Kidney Disease: The Story is Evolving!;American Journal of Kidney Diseases;2024-09

3. Nephrologists’ Views on a Workflow for Returning Genetic Results to Research Participants;Kidney International Reports;2024-09

4. APOL1-Mediated Kidney Disease;JAMA;2024-05-21

5. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders;eBioMedicine;2024-03